MS Therapy Centre

Information About our News Feeds

The News Feeds displayed on this page are collected and updated from reputable 3rd Party Resources and Publications both National and International. The Wolverhampton MS Therapy Centre takes care in only including those resources it feels may benefit its Clients and Carers.

Occasionally some News Feeds are not made available for us to display and an error message may appear above, this simply means that a particular news article about MS is not available and does not affect the integrity of this site.

The Wolverhampton MS Therapy Centre cannot accept any legal responsibility for the accuracy or relevance of any information or any consequences that may arise from any actions taken from any information made available from the supplied News Feeds.

All information that is collected and displayed is offered in good faith.

Latest Multiple Sclerosis News

Long-term IFN-Beta Treatment Normalizes Immune Balance in RRMS, Study Shows
Multiple Sclerosis News Today Nov 12, 2019 | 07:15 am
Long-term treatment with interferon beta (IFN-beta) corrects the defective immune balance characteristic of people with relapsing-remitting multiple sclerosis (RRMS), a study has found. The study also identified more than 200 genes with significantly different activity between complete and partial responders to IFN-beta[…]
Read more...
Acthar Gel Quite Effective at Resolving Relapses as Alternative to Corticosteroids, Study Reports
Multiple Sclerosis News Today Nov 12, 2019 | 07:00 am
Acthar Gel is more effective for treating flares in multiple sclerosis than other alternatives, including intravenous immunoglobulin or plasmapheresis, a claims-based study from Mallinckrodt Pharmaceuticals reports.The study "Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population" was published[…]
Read more...
Tecfidera Generic Granted Tentative FDA Approval as Patent Assault Continues
Multiple sclerosis on Neurology Times Oct 16, 2019 | 12:36 pm
The latest generic entry comes on the heels of a new report from ICER, which published a list of prescription drugs that had substantial price increases in 2017 and 2018 without what they consider to be new supporting evidence.
Read more...
Siponimod Delays Time to Wheelchair in Secondary Progressive MS
Multiple sclerosis on Neurology Times Oct 2, 2019 | 11:52 am
After showing significant benefits in delayed disease progression in patients with secondary progressive MS, new data suggests siponimod can delay the time to wheelchair dependence by 4 years.
Read more...
Video Campaigns
Society for Multiple Sclerosis Patients in Pakistan Jun 13, 2018 | 02:08 am
Apart from the #LetsBeatMS campaign, the Radio Campaign, and Media Coverage, the Society for Multiple Sclerosis Patients in Pakistan also started a Video campaign on Social Media Platforms. The first video was a mini documentary on my Life with MS,[…]
Read more...
Media Coverage
Society for Multiple Sclerosis Patients in Pakistan Jun 12, 2018 | 11:22 am
The Society for Multiple Sclerosis Patients in Pakistan gave several interviews to News channels around World MS Day 2018 to help raise awareness about Multiple Sclerosis. The interviews were broadcasted on Royal News. Another interview was given to Muhammad Rizwan[…]
Read more...